151 related articles for article (PubMed ID: 1731324)
1. Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit.
Tyrrell GJ; Ramotar K; Toye B; Boyd B; Lingwood CA; Brunton JL
Proc Natl Acad Sci U S A; 1992 Jan; 89(2):524-8. PubMed ID: 1731324
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
[TBL] [Abstract][Full Text] [Related]
3. Globotetraosylceramide is recognized by the pig edema disease toxin.
DeGrandis S; Law H; Brunton J; Gyles C; Lingwood CA
J Biol Chem; 1989 Jul; 264(21):12520-5. PubMed ID: 2663859
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
[TBL] [Abstract][Full Text] [Related]
5. Modeling the carbohydrate-binding specificity of pig edema toxin.
Cummings MD; Ling H; Armstrong GD; Brunton JL; Read RJ
Biochemistry; 1998 Feb; 37(7):1789-99. PubMed ID: 9485304
[TBL] [Abstract][Full Text] [Related]
6. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
Ghislain J; Lingwood CA; Fish EN
J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
[TBL] [Abstract][Full Text] [Related]
7. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
Kiarash A; Boyd B; Lingwood CA
J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
[TBL] [Abstract][Full Text] [Related]
8. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
[TBL] [Abstract][Full Text] [Related]
10. A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity.
Ling H; Pannu NS; Boodhoo A; Armstrong GD; Clark CG; Brunton JL; Read RJ
Structure; 2000 Mar; 8(3):253-64. PubMed ID: 10745005
[TBL] [Abstract][Full Text] [Related]
11. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.
Acheson DW; Jacewicz M; Kane AV; Donohue-Rolfe A; Keusch GT
Microb Pathog; 1993 Jan; 14(1):57-66. PubMed ID: 8321118
[TBL] [Abstract][Full Text] [Related]
12. Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides.
Head S; Ramotar K; Lingwood C
Infect Immun; 1990 Jun; 58(6):1532-7. PubMed ID: 2160427
[TBL] [Abstract][Full Text] [Related]
13. Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3).
Nyholm PG; Brunton JL; Lingwood CA
Int J Biol Macromol; 1995 Jun; 17(3-4):199-204. PubMed ID: 7577818
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to verotoxin as a function of the cell cycle.
Pudymaitis A; Lingwood CA
J Cell Physiol; 1992 Mar; 150(3):632-9. PubMed ID: 1537890
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
Cooling LL; Walker KE; Gille T; Koerner TA
Infect Immun; 1998 Sep; 66(9):4355-66. PubMed ID: 9712788
[TBL] [Abstract][Full Text] [Related]
16. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
[TBL] [Abstract][Full Text] [Related]
17. The binding mechanism of the virulence factor
Madar Johansson M; Bélurier E; Papageorgiou AC; Sundin AP; Rahkila J; Kallonen T; Nilsson UJ; Maatsola S; Nyholm TKM; Käpylä J; Corander J; Leino R; Finne J; Teneberg S; Haataja S
J Biol Chem; 2020 Oct; 295(42):14305-14324. PubMed ID: 32796033
[No Abstract] [Full Text] [Related]
18. Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.
Lingwood CA; Yiu SK
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):25-6. PubMed ID: 1314564
[TBL] [Abstract][Full Text] [Related]
19. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis.
Maloney MD; Lingwood CA
J Exp Med; 1994 Jul; 180(1):191-201. PubMed ID: 7516406
[TBL] [Abstract][Full Text] [Related]
20. Identification of glycosphingolipid receptors for pierisin-1, a guanine-specific ADP-ribosylating toxin from the cabbage butterfly.
Matsushima-Hibiya Y; Watanabe M; Hidari KI; Miyamoto D; Suzuki Y; Kasama T; Kasama T; Koyama K; Sugimura T; Wakabayashi K
J Biol Chem; 2003 Mar; 278(11):9972-8. PubMed ID: 12645583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]